X
Xin Yu
Researcher at Amgen
Publications - 32
Citations - 4839
Xin Yu is an academic researcher from Amgen. The author has contributed to research in topics: T cell & TIGIT. The author has an hindex of 19, co-authored 27 publications receiving 3517 citations. Previous affiliations of Xin Yu include Rockefeller University & Genentech.
Papers
More filters
Journal ArticleDOI
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
Xin Yu,Kristin Harden,Lino C. Gonzalez,Michelle Francesco,Eugene Chiang,Bryan Irving,Irene Tom,Sinisa Ivelja,Canio J. Refino,Hilary Clark,Dan L. Eaton,Jane L. Grogan +11 more
TL;DR: The data suggest that TIGIT exerts immunosuppressive effects by binding to poliovirus receptor and modulating cytokine production by dendritic cells.
Journal ArticleDOI
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston,Laetitia Comps-Agrar,Jason A. Hackney,Xin Yu,Mahrukh Huseni,Yagai Yang,Summer Park,Vincent Javinal,Henry Chiu,Bryan Irving,Dan L. Eaton,Jane L. Grogan +11 more
TL;DR: A key role is defined for TIGIT in inhibiting chronic CD8(+) T cell-dependent responses to tumor formation and chronic immune responses to chronic viral infection.
Journal ArticleDOI
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.
Lei Zhang,Xin Yu,Liangtao Zheng,Yuanyuan Zhang,Yansen Li,Qiao Fang,Ranran Gao,Boxi Kang,Qiming Zhang,Julie Y. Huang,Hiroyasu Konno,Guo Xinyi,Yingjiang Ye,Songyuan Gao,Shan Wang,Xueda Hu,Xianwen Ren,Zhanlong Shen,Wenjun Ouyang,Zemin Zhang +19 more
TL;DR: An integrated RNA-sequencing approach demonstrates that CXCL13+ TH1-like cells are preferentially enriched in microsatellite-instable tumours from patients with colorectal cancer, and IGFLR1 is identified as a co-stimulatory molecule.
Journal ArticleDOI
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.
Lei Zhang,Ziyi Li,Katarzyna M. Skrzypczynska,Qiao Fang,Wei Zhang,Sarah A. O’Brien,Yao He,Lynn Wang,Qiming Zhang,Aeryon Kim,Ranran Gao,Jessica Orf,Tao Wang,Deepali V. Sawant,Jiajinlong Kang,Dev Bhatt,Daniel Lu,Chi-Ming Li,Aaron S. Rapaport,Kristy Perez,Yingjiang Ye,Shan Wang,Xueda Hu,Xianwen Ren,Wenjun Ouyang,Zhanlong Shen,Jackson G. Egen,Zemin Zhang,Xin Yu +28 more
TL;DR: This comprehensive analysis of key myeloid subsets in human and mouse identifies critical cellular interactions regulating tumor immunity and defines mechanisms underlying myeloids-targeted immunotherapies currently undergoing clinical testing.
Journal ArticleDOI
The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression
TL;DR: The results show that the BRCT domains interact in vivo with CtIP, a protein originally identified on the basis of its association with the CtBP transcriptional co-repressor, suggesting that BRCA1 regulates gene expression, at least in part, by modulating CtBP-mediated transcriptional repression.